354 related articles for article (PubMed ID: 24709991)
1. Association of serum irisin with metabolic syndrome in obese Chinese adults.
Yan B; Shi X; Zhang H; Pan L; Ma Z; Liu S; Liu Y; Li X; Yang S; Li Z
PLoS One; 2014; 9(4):e94235. PubMed ID: 24709991
[TBL] [Abstract][Full Text] [Related]
2. Association of serum irisin and body composition with chronic kidney disease in obese Chinese adults: a cross-sectional study.
Yang S; Xiao F; Pan L; Zhang H; Ma Z; Liu S; Liu Y; Zhang W; Zeng X; Liu C; Li X; Li X; Li Z
BMC Nephrol; 2015 Feb; 16():16. PubMed ID: 25884312
[TBL] [Abstract][Full Text] [Related]
3. Circulating irisin in relation to insulin resistance and the metabolic syndrome.
Park KH; Zaichenko L; Brinkoetter M; Thakkar B; Sahin-Efe A; Joung KE; Tsoukas MA; Geladari EV; Huh JY; Dincer F; Davis CR; Crowell JA; Mantzoros CS
J Clin Endocrinol Metab; 2013 Dec; 98(12):4899-907. PubMed ID: 24057291
[TBL] [Abstract][Full Text] [Related]
4. Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.
Saber GY; Kasabri V; Saleh MI; Suyagh M; Halaseh L; Jaber R; Abu-Hassan H; Alalawi S
Horm Mol Biol Clin Investig; 2019 Mar; 38(1):. PubMed ID: 30840586
[TBL] [Abstract][Full Text] [Related]
5. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents.
Jang HB; Kim HJ; Kang JH; Park SI; Park KH; Lee HJ
Metabolism; 2017 Aug; 73():100-108. PubMed ID: 28732566
[TBL] [Abstract][Full Text] [Related]
6. Elevated circulating irisin is associated with lower risk of insulin resistance: association and path analyses of obese Chinese adults.
Shi X; Lin M; Liu C; Xiao F; Liu Y; Huang P; Zeng X; Yan B; Liu S; Li X; Yang S; Li X; Li Z
BMC Endocr Disord; 2016 Jul; 16(1):44. PubMed ID: 27473122
[TBL] [Abstract][Full Text] [Related]
7. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
[TBL] [Abstract][Full Text] [Related]
8. The relationship of irisin with metabolic syndrome components and insulin secretion and resistance in schoolchildren.
Wu CZ; Chu NF; Chang LC; Cheng CW; Lin YF; Pei D; Fang TC; Chen JS
Medicine (Baltimore); 2021 Feb; 100(5):e24061. PubMed ID: 33592858
[TBL] [Abstract][Full Text] [Related]
9. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults.
Zhang HJ; Zhang XF; Ma ZM; Pan LL; Chen Z; Han HW; Han CK; Zhuang XJ; Lu Y; Li XJ; Yang SY; Li XY
J Hepatol; 2013 Sep; 59(3):557-62. PubMed ID: 23665283
[TBL] [Abstract][Full Text] [Related]
10. The Levels of Serum Irisin as a Predictor of Insulin Resistance in Han Chinese Adults with Metabolically Healthy Obesity.
Liu BW; Yin FZ; Qi XM; Fan DM; Zhang Y
Clin Lab; 2017 May; 63(5):881-886. PubMed ID: 28627815
[TBL] [Abstract][Full Text] [Related]
11. Association of Circulating Irisin Levels with Adiposity and Glucose Metabolic Profiles in a Middle-Aged Chinese Population: A Cross-Sectional Study.
Zhang R; Fu T; Zhao X; Qiu Y; Hu X; Shi H; Yin X
Diabetes Metab Syndr Obes; 2020; 13():4105-4112. PubMed ID: 33162755
[TBL] [Abstract][Full Text] [Related]
12. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
13. Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study.
Cai C; Lin M; Xu Y; Li X; Yang S; Zhang H
BMC Med; 2016 Oct; 14(1):165. PubMed ID: 27772531
[TBL] [Abstract][Full Text] [Related]
14. Association of Markers of Proinflammatory Phenotype and Beige Adipogenesis with Metabolic Syndrome in Chinese Centrally Obese Adults.
Leung WKC; Yu AP; Lai CWK; Siu PM
J Diabetes Res; 2018; 2018():8956509. PubMed ID: 29670915
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
16. Irisin is a biomarker for metabolic syndrome in prepubertal children.
Shim YS; Kang MJ; Yang S; Hwang IT
Endocr J; 2018 Jan; 65(1):23-31. PubMed ID: 28904307
[TBL] [Abstract][Full Text] [Related]
17. The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype.
Hwang YC; Jeon WS; Park CY; Youn BS
Cardiovasc Diabetol; 2016 Jan; 15():9. PubMed ID: 26790404
[TBL] [Abstract][Full Text] [Related]
18. The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome.
Tabak O; Simsek G; Erdenen F; Sozer V; Hasoglu T; Gelisgen R; Altunoglu E; Muderrisoglu C; Senyigit A; Uzun H
Arch Endocrinol Metab; 2017 Dec; 61(6):515-523. PubMed ID: 28977161
[TBL] [Abstract][Full Text] [Related]
19. Irisin levels in genetic and essential obesity: clues for a potential dual role.
Mai S; Grugni G; Mele C; Vietti R; Vigna L; Sartorio A; Aimaretti G; Scacchi M; Marzullo P
Sci Rep; 2020 Jan; 10(1):1020. PubMed ID: 31974460
[TBL] [Abstract][Full Text] [Related]
20. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
